Esophageal Carcinoma — Research

Esophageal Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-11	39,354	`("Esophageal Carcinoma"[tiab] OR "ESCA"[tiab] OR "Esophageal Cancer"[tiab] OR "Esophagus Carcinoma"[tiab] OR "Carcinoma of Esophagus"[tiab] OR "Carcinoma of the Esophagus"[tiab])`	2026-09-11	pubmed
Last 5 years	2021-01-01 → 2026-12-31	12,158	`("Esophageal Carcinoma"[tiab] OR "ESCA"[tiab] OR "Esophageal Cancer"[tiab] OR "Esophagus Carcinoma"[tiab] OR "Carcinoma of Esophagus"[tiab] OR "Carcinoma of the Esophagus"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-11	pubmed
Last 12 months	2025-09-11 → 2026-09-11	2,284	`("Esophageal Carcinoma"[tiab] OR "ESCA"[tiab] OR "Esophageal Cancer"[tiab] OR "Esophagus Carcinoma"[tiab] OR "Carcinoma of Esophagus"[tiab] OR "Carcinoma of the Esophagus"[tiab]) AND (2025/09/11:2026/09/11[dp])`	2026-09-11	pubmed

Data updated 19 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (12)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–12 of 12 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
· Ann Surg Oncol · 2010 · PMID 19941080 · validated civic_curation pubmed
The AXL receptor tyrosine kinase is associated with adverse prognosis and distant metastasis in esophageal squamous cell carcinoma.
· Oncotarget · 2016 · PMID 27172793 · validated civic_curation pubmed
Homogeneous EGFR amplification defines a subset of aggressive Barrett's adenocarcinomas with poor prognosis.
· Histopathology · 2010 · PMID 20840671 · validated civic_curation pubmed
The relation of EGFR expression by immunohistochemical staining and clinical response of combination treatment of nimotuzumab and chemotherapy in esophageal squamous cell carcinoma.